Morgan Stanley Ideaya Biosciences, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,453,377 shares of IDYA stock, worth $34.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,453,377

Previous 1,686,588 13.83%

Holding current value

$34.3 Million

Previous $27.6 Million 10.58%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$14.5 - $22.63 $3.38 Million - $5.28 Million	-233,211 Reduced 13.83%	1,453,377 $30.5 Million
Q1 2025 May 15, 2025	BUY	$16.38 - $26.0 $2.15 Million - $3.42 Million	131,508 Added 8.46%	1,686,588 $27.6 Million
Q4 2024 Feb 14, 2025	BUY	$24.79 - $31.98 $29.6 Million - $38.2 Million	1,194,443 Added 331.2%	1,555,080 $40 Million
Q3 2024 May 14, 2025	SELL	$30.37 - $43.05 $12.9 Million - $18.2 Million	-423,488 Reduced 54.01%	360,637 $11.4 Million
Q3 2024 Nov 14, 2024	SELL	$30.37 - $43.05 $12.9 Million - $18.2 Million	-423,488 Reduced 54.01%	360,637 $11.4 Million
Q2 2024 May 14, 2025	SELL	$34.37 - $43.46 $26.5 Million - $33.5 Million	-770,955 Reduced 49.58%	784,125 $27.5 Million
Q2 2024 Oct 17, 2024	BUY	$34.37 - $43.46 $704,825 - $891,234	20,507 Added 2.69%	784,125 $27.5 Million
Q2 2024 Aug 14, 2024	BUY	$34.37 - $43.46 $704,825 - $891,234	20,507 Added 2.69%	784,125 $27.5 Million
Q1 2024 Oct 17, 2024	SELL	$34.2 - $47.13 $701,339 - $966,494	-20,507 Reduced 2.62%	763,618 $33.5 Million
Q1 2024 Aug 16, 2024	SELL	$34.2 - $47.13 $16.1 Million - $22.1 Million	-469,653 Reduced 38.08%	763,618 $33.5 Million
Q1 2024 May 15, 2024	SELL	$34.2 - $47.13 $16.1 Million - $22.1 Million	-469,653 Reduced 38.08%	763,618 $33.5 Million
Q4 2023 Aug 16, 2024	BUY	$24.59 - $35.83 $11 Million - $16.1 Million	449,146 Added 57.28%	1,233,271 $43.9 Million
Q4 2023 Feb 13, 2024	BUY	$24.59 - $35.83 $24.6 Million - $35.8 Million	1,000,495 Added 429.81%	1,233,271 $43.9 Million
Q3 2023 Nov 15, 2023	SELL	$21.07 - $29.77 $2.52 Million - $3.57 Million	-119,790 Reduced 33.98%	232,776 $6.28 Million
Q2 2023 Aug 14, 2023	BUY	$13.33 - $25.53 $3.49 Million - $6.68 Million	261,814 Added 288.49%	352,566 $8.29 Million
Q1 2023 May 15, 2023	BUY	$13.49 - $18.72 $440,246 - $610,927	32,635 Added 56.15%	90,752 $1.25 Million
Q4 2022 Feb 14, 2023	BUY	$14.47 - $18.17 $131,459 - $165,074	9,085 Added 18.53%	58,117 $1.06 Million
Q3 2022 Nov 14, 2022	SELL	$9.24 - $15.79 $342,092 - $584,593	-37,023 Reduced 43.02%	49,032 $732,000
Q2 2022 Oct 27, 2022	SELL	$8.28 - $13.88 $288,011 - $482,801	-34,784 Reduced 28.79%	86,055 $1.19 Million
Q2 2022 Aug 15, 2022	SELL	$8.28 - $13.88 $288,011 - $482,801	-34,784 Reduced 28.79%	86,055 $1.19 Million
Q1 2022 Oct 27, 2022	BUY	$11.18 - $24.02 $388,885 - $835,511	34,784 Added 40.42%	120,839 $1.35 Million
Q1 2022 May 13, 2022	BUY	$11.18 - $24.02 $912,802 - $1.96 Million	81,646 Added 208.32%	120,839 $1.35 Million
Q4 2021 Feb 14, 2022	BUY	$20.95 - $26.88 $247,419 - $317,452	11,810 Added 43.13%	39,193 $926,000
Q3 2021 Nov 15, 2021	BUY	$17.26 - $27.08 $472,630 - $741,531	27,383 New	27,383 $698,000

Others Institutions Holding IDYA

# of Institutions

215

Shares Held

83.4M

Call Options Held

28.7K

Put Options Held

132K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.13B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account